87 related articles for article (PubMed ID: 19507233)
1. The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells.
Lee LH; Moh MC; Zhang T; Shen S
J Cell Biochem; 2009 Aug; 107(6):1129-38. PubMed ID: 19507233
[TBL] [Abstract][Full Text] [Related]
2. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma.
Chung Moh M; Hoon Lee L; Shen S
J Hepatol; 2005 Jun; 42(6):833-41. PubMed ID: 15885354
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the immunoglobulin-like cell adhesion molecule hepaCAM with caveolin-1.
Moh MC; Lee LH; Zhang T; Shen S
Biochem Biophys Res Commun; 2009 Jan; 378(4):755-60. PubMed ID: 19059381
[TBL] [Abstract][Full Text] [Related]
5. The immunoglobulin-like cell adhesion molecule hepaCAM is cleaved in the human breast carcinoma MCF7 cells.
Zhang T; Moh MC; Lee LH; Shen S
Int J Oncol; 2010 Jul; 37(1):155-65. PubMed ID: 20514407
[TBL] [Abstract][Full Text] [Related]
6. Expression of hepaCAM and its effect on proliferation of tumor cells in renal cell carcinoma.
Xun C; Luo C; Wu X; Zhang Q; Yan L; Shen S
Urology; 2010 Apr; 75(4):828-34. PubMed ID: 20110109
[TBL] [Abstract][Full Text] [Related]
7. The immunoglobulin-like cell adhesion molecule hepaCAM modulates cell adhesion and motility through direct interaction with the actin cytoskeleton.
Moh MC; Tian Q; Zhang T; Lee LH; Shen S
J Cell Physiol; 2009 May; 219(2):382-91. PubMed ID: 19142852
[TBL] [Abstract][Full Text] [Related]
8. HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma.
Zhang QL; Luo CL; Wu XH; Wang CY; Xu X; Zhang YY; Liu Q; Shen SL
J Cell Biochem; 2011 Oct; 112(10):2910-9. PubMed ID: 21618595
[TBL] [Abstract][Full Text] [Related]
9. The in vitro influences of neurotensin on the motility characteristics of human U373 glioblastoma cells.
Servotte S; Camby I; Debeir O; Deroanne C; Lambert CA; Lapière CM; Kiss R; Nusgens B; Decaestecker C
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):575-84. PubMed ID: 17083472
[TBL] [Abstract][Full Text] [Related]
10. HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin.
Svechnikova I; Almqvist PM; Ekström TJ
Int J Oncol; 2008 Apr; 32(4):821-7. PubMed ID: 18360709
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted role of galectin-3 on human glioblastoma cell motility.
Debray C; Vereecken P; Belot N; Teillard P; Brion JP; Pandolfo M; Pochet R
Biochem Biophys Res Commun; 2004 Dec; 325(4):1393-8. PubMed ID: 15555581
[TBL] [Abstract][Full Text] [Related]
12. GlialCAM, an immunoglobulin-like cell adhesion molecule is expressed in glial cells of the central nervous system.
Favre-Kontula L; Rolland A; Bernasconi L; Karmirantzou M; Power C; Antonsson B; Boschert U
Glia; 2008 Apr; 56(6):633-45. PubMed ID: 18293412
[TBL] [Abstract][Full Text] [Related]
13. Purification of the extracellular domain of the membrane protein GlialCAM expressed in HEK and CHO cells and comparison of the glycosylation.
Gaudry JP; Arod C; Sauvage C; Busso S; Dupraz P; Pankiewicz R; Antonsson B
Protein Expr Purif; 2008 Mar; 58(1):94-102. PubMed ID: 18082421
[TBL] [Abstract][Full Text] [Related]
14. Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative versus Invasive Cell States in Glioblastoma.
De A; Lattier JM; Morales JE; Kelly JR; Zheng X; Chen Z; Sebastian S; Nassiri Toosi Z; Huse JT; Lang FF; McCarty JH
J Neurosci; 2023 Nov; 43(47):8043-8057. PubMed ID: 37722850
[TBL] [Abstract][Full Text] [Related]
15. Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4.
Wang L; Tabu K; Kimura T; Tsuda M; Linghu H; Tanino M; Kaneko S; Nishihara H; Tanaka S
Biochem Biophys Res Commun; 2007 Nov; 362(4):976-81. PubMed ID: 17825249
[TBL] [Abstract][Full Text] [Related]
16. Differentially expressed genes from the glioblastoma cell line SHG-44 treated with all-trans retinoic acid in vitro.
Zeng Y; Yang Z; Xu JG; Yang MS; Zeng ZX; You C
J Clin Neurosci; 2009 Feb; 16(2):285-94. PubMed ID: 19091570
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15).
Cai M; Han L; Chen R; Ye F; Wang B; Han F; Lei T; Guo D
Cancer Lett; 2009 Jun; 278(1):104-12. PubMed ID: 19200647
[TBL] [Abstract][Full Text] [Related]
18. Dynamic characterization of glioblastoma cell motility.
De Hauwer C; Camby I; Darro F; Decaestecker C; Gras T; Salmon I; Kiss R; Van Ham P
Biochem Biophys Res Commun; 1997 Mar; 232(2):267-72. PubMed ID: 9125161
[TBL] [Abstract][Full Text] [Related]
19. Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines.
Strelau J; Schmeer C; Peterziel H; Sackmann T; Herold-Mende C; Steiner H; Weller M; Unsicker K
Cancer Lett; 2008 Oct; 270(1):30-9. PubMed ID: 18550273
[TBL] [Abstract][Full Text] [Related]
20. Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Cancer Res; 2009 Oct; 69(20):7953-9. PubMed ID: 19808959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]